IllinoisHB5148104th General Assembly (2025–2026)HouseWALLET

CONT SUB-PMP-SCHEDULE II&IV

Sponsored By: Sponsor information unavailable

Became Law

Summary

Amends the Illinois Controlled Substances Act. Provides that each prescriber or the prescriber's designee shall document an attempt to access patient information in the Prescription Monitoring Program to assess patient access to controlled substances when providing a (rather than an initial) prescription for Schedule II and IV controlled substances (rather than narcotics such as opioids), except for prescriptions for oncology treatment or palliative care, or a 7-day or less supply provided by a hospital emergency department when treating an acute, traumatic medical condition.

health care licensesassignments

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

4 provisions identified: 3 benefits, 0 costs, 1 mixed.

Tougher rules on controlled substance shopping

It is illegal to knowingly or intentionally try to get a controlled substance or prescription from a second prescriber or dispenser by fraud without telling them you already have one. It is also illegal to do this across pharmacies without disclosing your existing supply. Medication or pharmacy shopping can be charged under state drug and food laws. These rules do not apply to hospital inpatients, residents in institutions, or institutional pharmacies.

Prescribers must use the drug-monitoring system

Beginning January 1, 2018, prescribers with an Illinois controlled‑substances license must register with the Prescription Monitoring Program. For an initial Schedule II stimulant, Schedule II opioid, or a Schedule IV benzodiazepine or narcotic opioid, the prescriber or a designee must try to check the system and record that attempt in the medical record. This check is not required for oncology or palliative care, or for a hospital emergency department supply of 7 days or less for an acute, traumatic condition. Hospitals must let prescribers name designees who can access the system for hospital services. If tech or power problems prevent registration, the prescriber is protected from criminal charges and discipline. The program can send reports when a person has five or more prescribers or five or more pharmacies in six months, and it also sends the report to the dispensing pharmacy.

Protects prescribers' judgment and no duty to report

Prescribers and pharmacists are not required to ask about patient medications, report patient activity, or prescribe or refuse any drug. A prescriber or dispenser cannot face adverse job or credentialing action based only on patient complaints that oppose a decision not to prescribe a controlled substance.

Veterinarians exempt from drug-monitoring system

Beginning on the effective date, licensed veterinarians do not have to register with the Prescription Monitoring Program. They are not allowed to access patient information in the system. Any veterinarians already registered are removed.

Sponsors & Cosponsors

Sponsors

There is no primary sponsor on record.

Cosponsors

  • Janet Yang Rohr

    Affiliation unavailable

  • Julie A. Morrison

    Affiliation unavailable

Roll Call Votes

All Roll Calls

Yes: 184 • No: 0

Senate vote 5/14/2026

Third Reading - Passed;

Yes: 58 • No: 0

House vote 4/14/2026

Third Reading - Short Debate - Passed

Yes: 111 • No: 0

House vote 3/19/2026

Do Pass as Amended / Short Debate Health Care Licenses Committee;

Yes: 15 • No: 0

Actions Timeline

  1. Public Act . . . . . . . . . 104-0512

    6/26/2026House
  2. Effective Date January 1, 2027

    6/26/2026House
  3. Governor Approved

    6/26/2026House
  4. Sent to the Governor

    6/12/2026House
  5. Passed Both Houses

    5/14/2026House
  6. Third Reading - Passed; 058-000-000

    5/14/2026Senate
  7. Placed on Calendar Order of 3rd Reading May 5, 2026

    4/30/2026Senate
  8. Second Reading

    4/30/2026Senate
  9. Placed on Calendar Order of 2nd Reading April 29, 2026

    4/28/2026Senate
  10. Approved for Consideration Assignments

    4/28/2026Senate
  11. Alternate Chief Sponsor Changed to Sen. Julie A. Morrison

    4/17/2026Senate
  12. Referred to Assignments

    4/15/2026Senate
  13. First Reading

    4/15/2026Senate
  14. Chief Senate Sponsor Sen. Ram Villivalam

    4/15/2026Senate
  15. Placed on Calendar Order of First Reading

    4/15/2026Senate
  16. Arrive in Senate

    4/15/2026Senate
  17. Third Reading - Short Debate - Passed 111-000-000

    4/14/2026House
  18. Placed on Calendar Order of 3rd Reading - Short Debate

    4/14/2026House
  19. Held on Calendar Order of Second Reading - Short Debate

    4/10/2026House
  20. Second Reading - Short Debate

    4/10/2026House
  21. Placed on Calendar 2nd Reading - Short Debate

    3/19/2026House
  22. Do Pass as Amended / Short Debate Health Care Licenses Committee; 015-000-000

    3/19/2026House
  23. House Committee Amendment No. 1 Adopted in Health Care Licenses Committee; by Voice Vote

    3/19/2026House
  24. House Committee Amendment No. 1 Rules Refers to Health Care Licenses Committee

    3/18/2026House
  25. House Committee Amendment No. 1 Referred to Rules Committee

    3/17/2026House

Bill Text

Related Bills

Back to State Legislation